Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASIS for Enbrel in Plaque Psoriasis

NCT02112097 is registered in ClinicalTrials.gov with ASIS Corporation as lead sponsor.

NCT NCT02112097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02112097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASIS for Enbrel in Plaque Psoriasis
Lead sponsor
ASIS Corporation
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2016
Completion date
June 30, 2017
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis.